Mobile health ultrasound for breast cancer diagnosis in Nigeria
Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria
This study is testing a training program for Nigerian radiologists to help them use ultrasound to safely perform breast biopsies for women with suspicious breast lumps.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 600 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Memorial Sloan Kettering Cancer Center Academic / other |
| Locations | 1 site (Ile-Ife) |
| Trial ID | NCT04501419 on ClinicalTrials.gov |
What this trial studies
This study aims to train Nigerian radiologists in performing ultrasound-guided breast biopsies for women presenting with suspicious breast masses. The training program is competency-based and developed by experts from both Nigeria and the USA, ensuring that radiologists acquire the necessary skills to safely conduct these procedures. By enhancing local capabilities, the study seeks to improve breast cancer diagnosis and management in Nigeria.
Who should consider this trial
Good fit: Ideal candidates are women aged 18 and older with a breast ultrasound showing a solid mass that is suspicious for cancer.
Not a fit: Patients who are under 18 or unwilling to sign consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this could lead to earlier and more accurate breast cancer diagnoses for women in Nigeria.
How similar studies have performed: Other studies have shown success in training local healthcare providers in similar diagnostic techniques, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 and older female * Breast ultrasound demonstrating a solid mass that is suspicious for cancer, which would typically undergo either a blind biopsy or surgical excision at the Nigerian hospital where the patient is seeking diagnosis. Exclusion Criteria: * Participants unwilling to sign consent * Participants under the age of 18.
Where this trial is running
Ile-Ife
- Obafemi Awolowo University Teaching Hospitals Complex (OAUTHC) — Ile-Ife, Nigeria (Recruiting)
Study contacts
- Principal investigator: Adeleye Omisore, MD — Obafemi Awolowo University Teaching Hospitals
- Study coordinator: Adeleye Omisore, MD
- Email: omisoreadeleye@yahoo.com
- Phone: +2348031538004
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.